In 30 patients aged 12-40 receiving second or subsequent doses of the COVID mrna Vaccines active surveillance with high sensitivity cardiac biomarkers revealed no subclinical or clinical myocarditis.
Tiny study, only 16 men. Average age 29. So we know the rate of clinical /…